Mixture multi-state Markov regression model

Journal of Applied Statistics

Volumn 34, Issue 1, 2007, Pages 11-21

  Ming Fang Yen, Amy ^a   Hsiu Hsi Chen, Tony ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Markov mixture model; Model selection; Multi state

Indexed keywords

EID: 33845947914     PISSN: 02664763     EISSN: 13600532     Source Type: Journal    
DOI: 10.1080/02664760600994711     Document Type: Article

References (17)

1. Boily, M. and Masse, B. and Desai, K. and Alary, M. and Anderson, R. (1999) Some important issues in the planning of phase III HIV vaccine efficacy trials Vaccine, 17, pp. 989-1004.
2. Breslow, N. and Clayton, D. (1993) Approximate inference in generalized linear mixed models Journal of the American Statistical Association, 88, pp. 9-25.
3. Cox, D. and Miller, H.(1965) The Theory of Stochastic Process. London: Methuen.
4. Desai, K. and Boily, M. and Masse, B. and Alary, M. and Anderson, R. (1999) Simulation studies of phase III clinical trials to test the efficacy of a candidate HIV-1 vaccine Epidemiology and Infection, 123, pp. 65-88.
5. Halloran, M. and Longini, I. and Struchiner, C. (1996) Estimability and interpretation of vaccine efficacy using frailty mixing models American Journal of Epidemiology, 144, pp. 83-97.
6. Hougaard, P. and Myglegaard, P. and Borchjohnsen, K. (1994) Heterogeneity models of disease susceptibility, with application to diabetic nephropathy Biometrics, 50, pp. 1178-1188.
7. Hougaard, P. (1995) Frailty models for survival data Lifetime Data Analysis, 1(3), pp. 255-273.
8. Hsieh, H. and Chen, T. and Chang, S. (2002) Assessing chronic disease progression using non-homogeneous exponential regression Markov models: an illustration using a selective breast cancer screening in Taiwan Statistics in Medicine, 21(22), pp. 3369-3382.
9. Jackson, C. and Sharples, L. (2002) Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients Statistics in Medicine, 21(1), pp. 113-128.
10. Kalbfleisch, J. and Lawless, J. (1985) The analysis of panel data under a Markov assumption Journal of the American Statistical Association, 80, pp. 863-871.
11. Liao, C. and Yang, K. and Yen, M. and Teng, L. and Duffy, S. and Chen, T. (2002) Prognosis of small hepatocellular carcinoma treated by percutaneous ethanol injection and transcatheter arterial chemoembolization Journal of Clinical Epidemiology, 55(11), pp. 1095-1104.
12. Lin, L. and Lin, X. and He, Y. and Gao, S. and Xue, E. and Lin, X. and Yu, L. (2004) Experimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma World Journal of Gastroenterology, 10(21), pp. 3112-3117.
13. Longini, I. and Halloran, M. (1996) A frailty mixture model for estimating vaccine efficacy Applied Statistics-Journal of the Royal Statistical Society Series C, 45, pp. 165-173.
14. Morrison, A.(1992) Screening in Chronic Disease. Oxford: Oxford University Press.
15. Vaupel, J. and Manton, K. and Stallard, E. (1979) The impact of heterogeneity in individual frailty on the dynamics of mortality Demography, 16, pp. 439-454.
16. Wu, H. and Yen, M. and Chen, T. (2004) SAS macro program for non-homogeneous Markov process in modeling multi-state disease progression Computer Methods and Programs in Biomedicine, 75(2), pp. 95-105.
17. Zeger, S. and Liang, K. and Albert, P. (1988) Models for longitudinal data: A generalized estimating equation approach Biometrics, 44(4), pp. 1049-1060.